InterventionsHumans
Fracture Risk with Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes: A Target Trial Emulation
ADA Scientific Sessions 2026 Abstract
The paper
JIA X, HAN J, GUO X et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Late-breaking 2859-LB